Author: Peter Ashton Manhart
Publisher:
ISBN:
Category :
Languages : en
Pages : 364
Book Description
The intent and interpretation of federal laws concerning the regulation of business: American Oil Company vs. Federal Trade Commission, a case point of disparity
Author: Peter Ashton Manhart
Publisher:
ISBN:
Category :
Languages : en
Pages : 364
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 364
Book Description
The Antitrust Paradox
Author: Robert Bork
Publisher:
ISBN: 9781736089712
Category :
Languages : en
Pages : 536
Book Description
The most important book on antitrust ever written. It shows how antitrust suits adversely affect the consumer by encouraging a costly form of protection for inefficient and uncompetitive small businesses.
Publisher:
ISBN: 9781736089712
Category :
Languages : en
Pages : 536
Book Description
The most important book on antitrust ever written. It shows how antitrust suits adversely affect the consumer by encouraging a costly form of protection for inefficient and uncompetitive small businesses.
Report on the Robinson-Patman Act
Author: United States. Department of Justice
Publisher:
ISBN:
Category : Interstate commerce
Languages : en
Pages : 320
Book Description
Publisher:
ISBN:
Category : Interstate commerce
Languages : en
Pages : 320
Book Description
Guidelines Manual
Author: United States Sentencing Commission
Publisher:
ISBN:
Category : Criminal justice, Administration of
Languages : en
Pages : 556
Book Description
Publisher:
ISBN:
Category : Criminal justice, Administration of
Languages : en
Pages : 556
Book Description
Strategy, Predation, and Antitrust Analysis
Author: Steven C. Salop
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 772
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 772
Book Description
A.A. Poultry Farms, Inc. V. Rose Acre Farms, Inc
Report of the Attorney General's National Committee to Study the Antitrust Laws
Author: United States. Attorney General's National Committee to Study the Antitrust Laws
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 416
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 416
Book Description
Kraft, Inc. V. Federal Trade Commission
Annual Report of the Federal Trade Commission for the Fiscal Year Ended ...
Author: United States. Federal Trade Commission
Publisher:
ISBN:
Category : Trade regulation
Languages : en
Pages : 154
Book Description
Publisher:
ISBN:
Category : Trade regulation
Languages : en
Pages : 154
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.